Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab TherapyJ. von Schwarzenberg, Wei Chen, Whitney B. Pope et al.|Clinical Cancer Research|2014Cited by 140
3′-Deoxy-3′-<sup>18</sup>F-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with BevacizumabJ. von Schwarzenberg, Wei Chen, Johannes Czernin et al.|Journal of Nuclear Medicine|2011Cited by 133